drugset / Trial / NCT05876585

Clinical Trial to Investigate the Efficacy and Safety of Ondansetron (Danset - Adwia) Versus Placebo Plus the Standard of Care in the Treatment of Nausea and Vomiting in Adult Patients With Acute Gastroenteritis

NCT05876585

Phase 3 Not yet recruiting 126 enrolled Genuine Research Center, Egypt Adwia Pharma, Egypt · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

A Randomized, Open-label, Active-Controlled Clinical Trial to Investigate the Efficacy and Safety of Ondansetron compared to Metoclopramide in the management of Nausea and Vomiting in Adult Patients with Acute Gastroenteritis.

Timeline

Start
2025-06-01
Primary completion
2025-06-01
Completion
2025-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoclopramide Small molecule 10 mg
Subject Ondansetron Other / unclassified 8 mg Intravenous

Indications